CD304/neuropilin‐1 is a very useful and dependable marker for the measurable residual disease assessment of B‐cell precursor acute lymphoblastic leukemia - Concepedia

Concepedia

Publication | Open Access

CD304/neuropilin‐1 is a very useful and dependable marker for the measurable residual disease assessment of B‐cell precursor acute lymphoblastic leukemia

DOI Full Paper Access

21

Citations

37

References

2020

Year

Pratyusha Gudapati, Twinkle Khanka, Gaurav Chatterjee, Sitaram Ghogale, Yajamanam Badrinath, Nilesh Deshpande, Jagruti Patil, Gaurav Narula, Dhanalaxmi Shetty, Shripad Banavali,

Cytometry Part B Clinical Cytometry

Abstract

CD304 is commonly expressed in leukemic blasts of BCP-ALL. It is very useful in distinguishing residual disease from hematogones and is a fairly dependable marker. Hence, it is a valuable addition for enhancing the sensitivity and applicability of MFC-based MRD assay in BCP-ALL.

References

	Year	Citations

Page 1